CHARCOT-MARIE-TOOTH DISEASE, TYPE 1
Clinical trials for CHARCOT-MARIE-TOOTH DISEASE, TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new CHARCOT-MARIE-TOOTH DISEASE, TYPE 1 trials appear
Sign up with your email to follow new studies for CHARCOT-MARIE-TOOTH DISEASE, TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental stem cells tested for rare nerve disease
Disease control CompletedThis completed early trial tested a single intravenous dose of EN001 stem cells in 3 adults with Charcot-Marie-Tooth disease type 1E, a severe hereditary nerve disorder with no approved treatment. The main goal was to check safety, including infusion reactions, while also looking…
Matched conditions: CHARCOT-MARIE-TOOTH DISEASE, TYPE 1
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug shows promise for nerve disease that affects walking
Symptom relief CompletedThis study tested a new medicine called NMD670 in 81 adults with Charcot-Marie-Tooth disease types 1 and 2. Participants took either the drug or a placebo twice daily for 21 days. The main goal was to see if the drug could improve walking distance in 6 minutes. The study also che…
Matched conditions: CHARCOT-MARIE-TOOTH DISEASE, TYPE 1
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC